Abstract L-asparaginase (LA) catalyzes the degradation of asparagine, an essential amino acid for leukemic cells, into ammonia and aspartate. Owing to its ability to inhibit protein biosynthesis in lymphoblasts, LA is used to treat acute lymphoblastic leukemia (ALL). Different isozymes of this enzyme have been isolated from a wide range of organisms, including plants and terrestrial and marine microorganisms. Pieces of information about the three-dimensional structure of L-asparaginase from Escherichia coli and Erwinia sp. have identified residues that are essential for catalytic activity. This review catalogues the major sources of L-asparaginase, the methods of its production through the solid state (SSF) and submerged (SmF) fermentation, purification, and characterization as well as its biological roles. In the same breath, this article explores both the past and present applications of this important enzyme and discusses its future prospects.
Introduction
All enzymes are proteins (and in some cases RNA molecules) with varied functions. They catalyze reactions used in normal development, help in the maintenance of the cell, and work as defense against diseases. Enzymes can operate intracellularly, extracellularly, or even on the surface of a cell membrane [1] . Several hundred different enzymes have been identified, and many of them have been characterized to a considerable degree. Quite a few of these enzymes have future of particular interest and command the attention of loyal bands of investigators. However, only a relatively small number have moved to the center stage and turned into the objects of extensive investigations. According to Hammes, [2] , such enzymes come up with special experimental advantages. One of such enzymes is L-asparaginase. L-Asparaginase (Lasparagine amidohydrolase, EC 3.5.1.1) has been the focus of several papers in the most recent three decades. Although it does have certain features of interest, it must be admitted that Lasparaginase is not especially remarkable as an enzyme. What is unusual about asparaginase and constitutes the feature remarkable for the considerable attention it has attracted is its antineoplastic activity. L-asparaginase also known as aminohydrolase pertains to the amidase group of enzymes and can break down amino acid L-asparagine into aspartate and ammonia [3] (Fig. 1) .
L-asparaginase is the first therapeutic enzyme with antineoplastic properties that has been studied broadly by researchers and scientists far and wide. L-asparaginase was first observed by Lang in 1904 [4] . Research on physiological capabilities of L-asparaginase was under way for more than half century, and a real leap forward was accomplished in 1922 when Clementi [5] revealed the presence of L-asparaginase in blood serum of guinea pig. Kidd [6] in 1953 did a progression of experiments to prove the ability of guinea pig serum as tumor inhibitor. He carried out diverse sets of analysis where he concocted the findings that two sorts of subcutaneously executed lymphosarcoma in mice failed to proliferate once animals were given injections of guinea pig serum, while untreated controlled mice died because of carcinomas. In the second set of experiments, two different types of lymphomas namely mammary carcinoma and fibrosarcoma of mice failed to degenerate when treated with guinea pig serum. In 1961, yet another breakthrough was achieved when Broome [7] demonstrated L-asparaginase as an antitumor agent in guinea pig serum with substrate specificity. Later on, some other substratespecific L-asparaginases were found to inhibit tumors [8] [9] [10] . McCoy through his in vitro experiments proved the centrality of amino acid asparagine for Walker carcinoma 256 [11] . Altenbern in 1954 and Broome in 1965 reported the antitumor activity of L-asparaginase in bacteria and yeast, respectively [12, 13] . L-asparaginase is found in the serum of guinea pig and rodents but is absent in humans [14] . Tumors in mice, dogs, and rats can be regretted by the asparaginase enzyme purified from guinea pig serum, Escherichia coli, and to a lesser degree by the chicken liver [15] [16] [17] . Two isozymes of L-asparaginase, namely type I and type II, have been identified by Ohnuma in 1967 [18] . Both type I and type II asparaginases are characterized by enzymatic activity for both L-asparagine and L-glutamine. However, type II asparaginase displays higher specific action against L-asparagine. Type II asparaginase precisely shows antitumor activity and is utilized as chemotherapeutics in ALL [19] . Commercially available asparaginase includes Colapase, Crasnitin, Crisantas, Pasum, Kidrolase, Elspar, Erwinaze PEG-asparaginase, and Pegasparagasum. This paper reviews the different sources of L-asparaginase enzyme, methods that are being employed for its production, its assay methods, and its extensive applications in the health and food industry. Consequently, this review is organized in different sections. Section 1 sheds light on the structure, mode of action, and side effects of L-asparaginase. Section 2 gives insight into various sources of Lasparaginase enzyme including different microorganisms. Section 3 presents different production methods under submerged fermentation and solid state fermentation conditions and purification methods implemented for purification of L-asparaginase. Section 4 draws out the assay methods that are being used for detection of Lasparaginase. Section 5 discusses the applications in different areas including amino acid metabolism and clinical and food industry. Section 6 summarizes our conclusions and recommendations for future research on L-asparaginase.
L-Asparaginase Mechanism of Action
Because of its hydrolytic property, asparaginase is a cornerstone of treatment for ALL. Both normal and leukemic cells require the amino acid L-asparagine, for their metabolic needs. Normal cells can synthesize L-asparagine for their growth by utilizing transaminase enzyme that converts oxaloacetate into an intermediate aspartate, which later on transfers an amino group from glutamate to oxaloacetate producing α-ketoglutarate and aspartate. Finally, in healthy cells, aspartate is converted to asparagine by enzyme asparagine synthetase. Neoplastic cells lack the ability to synthesize the asparagine due to the absence of L-asparaginase synthetase enzyme, hence are dependent on the exogenous supply of asparagine for their existence and reproduction. Consequently, as a result, provision of L-asparaginase to tumor cells drains all circulating asparagine, which leads to starvation of cancer cells and ultimately they die off (Fig. 2) . Clinical data published over the last two decades suggests asparaginase is a very important component of treatment regimens for ALL. L-asparaginase is prevalent among eukaryotes and microorganisms [20] . L-asparaginase also has a potential role in the food industry as a food processor [21] .
L-Asparaginase Structure
Research has been carried out by many scientists to elucidate the structure of L-asparaginase enzyme at the molecular level. Usually, L-asparaginase exists as a tetramer but hexameric, dimeric, and monomeric forms are also found when isolated from different sources. Most bacterial L-asparaginases exhibit quaternary and tertiary structures [22] . Molecular structures of E. coli and Erwinia sp. are very well investigated, and their structural information is easily available [23, 24] . Both E. coli and Erwinia sp. have similar three-dimensional structures [25] . Erwinia carotovora enzyme consists of two tetramers (ABCD and EFGH) made up of four identical monomers (A to H) each. Three hundred twenty-seven amino acids assemble in each monomer with 14 α-strands, eight β-helices [26], and two domains, a big N-terminal domain and a small C-terminal domain [24] . The active site is positioned in between two adjacent monomers (A and C: B and D). The tetramer consists of four identical subunits. The whole molecule is considered as a dimer of dimers [27, 28] . Every active site is shaped by the conveyance of amino acids in two adjacent monomers. Following amino acids constitute active site: Thr15, Tyr29, Ser62, Glu63, Thr95, Asp 96, Ala120, and Lys168, while only one residue Ser254 is present in adjacent monomer [22, 27, [29] [30] [31] [32] [33] [34] . Thr15 and Thr95 are the residues responsible for the catalytic activity of the enzyme.
L-Asparaginase Side Effects
L-asparaginase causes certain side effects, and despite its potential antileukemic activity, utilization of L-asparaginase by leukemic patients causes lethality to normal cells. Lasparaginase produces a broad range of symptoms such as edema, skin rashes, fever, hepatic dysfunction, diabetes, leucopenia, pancreatitis, neurological seizures, and hemorrhage [35, 36] . Moola reported that some hypersensitivity reactions, mild allergic reactions, and anaphylactic shock are also caused by the usage of asparaginase-based drugs [37] . Adolescents appear to be at higher risk of neurotoxicity caused by L-asparaginase, which results in depression, fatigue, lethargy, dizziness, and agitation [38] . The toxicity of L-asparaginases is believed to be brought about by its glutaminase action [39] .
Sources of L-Asparaginase
The presence of L-asparaginase has been reported in various organisms, including animals, plants, and microorganisms (bacteria, fungi, algae, yeast, and actinomycetes) except humans. Even though L-asparaginase exists in several animal and plant groups, but owing to tiresome extraction procedures, other conceivable sources (bacteria, fungi, algae, yeasts, and actinomycetes) were explored by researchers. Large scale production of the enzyme from microbes is 
Bacterial Sources
L-asparaginase has been reported from both Gram-positive and Gram-negative bacterial species from the terrestrial and marine environment [41] . Gram-positive bacteria have gained less consideration as compared to Gram-negative [20] . More intensively studied species of both Gram-negative and Gram-positive classes are listed in Table 1 .
L-asparaginase from most of the Gram-negative bacteria can be categorized into two main types: type I and type II L-asparaginase. Type I L-asparaginase is expressed quantitatively and possesses enzymatic activity on both L-glutamine and L-asparagine amino acids, while type II L-asparaginase possesses high specific activity on L-asparagine and is only induced in anaerobic condition [80] . Type II L-asparaginase produced from E. coli (Ec AII) and Erwinia T. aquaticus [75] Vibrio succinogenes [76] Citrobacter freundi [77] Proteus vulgaris [78] Zymomonas mobilis [79] chrysanthemi (Er A) has been used as an antitumor agent for the effective treatment of ALL for over 30 years [81] . L-asparaginase from two bacterial sources like E. coli and E. carotovora is currently in clinical use for the treatment of acute lymphoblastic leukemia [82] .
Fungal Sources
Fungi are another potential source of L-asparaginase along with bacteria. Several adverse side effects linked with bacterial asparaginase often restrain their application. This impediment requests a quest for L-asparaginase from new sources. Human beings are more closely related to fungi as compared to bacteria. Hence, chances of immunological reaction against fungal asparaginase will be lesser [83] . Fungal asparaginase has acquired importance based on the fact that it is produced extracellularly, and it is a very easy to purify extracellular enzyme. Several L-asparaginase-producing fungi are being reported ( Table 2 ).
Yeast Sources
L-asparaginase with less injurious effects is reported from the yeast. Asparaginases reported from the yeasts including Saccharomyces sp., Candida sp., Pichia sp., Rhodotorula sp., Hansenula sp., and Spobolomyces sp., exhibit antitumor activity [93] . L-asparaginase-producing yeasts are listed in Table 3 .
Actinomycete Sources
L-asparaginase occurrence is also reported in actinomycetes [100] . Actinomycetes are pervasive worldwide in soil, water, and nature, but only those found in living animals especially in fishes are found to bear good enzymatic activity [101] . Moreover, actinomycetes are a better source of L-asparaginase when compared to bacteria and fungi [102] . Table 4 lists Lasparaginase-producing actinomycetes.
Algal Sources
Reports are available on the production of L-asparaginase from Chlamydomonas sp. [114] and a yellow green alga, Vaucheria uncinata [115] . A. niger [86] A. oryzae [87] A. tamarii [88] A. terreus [89] Cylidrocapron obtusisporum [90] Mucor sp.
[91]
Fusarium roseum [92] Production and Purification of L-Asparaginase Different methods reported for production and optimization of L-asparaginase from various microorganisms include solid state fermentation (SSF) and submerged fermentation (SmF) [93] . Reaction conditions vary from one organism to another for enzyme production, and it can be produced constitutively or after induction [116, 117] . SmF process has certain constraints like net yield is very low and costly. Whereas, SSF is cost-effective and yield of product is higher as compared to the SmF. Several methods have been reported for purification of Lasparaginase enzyme produced from various sources. The major suggested requisition of Lasparaginase is as an antileukemic drug that demands a very high level of purity for this enzyme. Most of the microbial asparaginases reported so far are intracellular in nature except for the few, which are extracellular [20] . Purification of intracellular asparaginases is tiresome as compared to extracellular enzymes. Detailed reaction conditions for production and purification of L-asparaginase using SSF and SmF from different microbes have been listed in Table 5 [94]. 
Assay Methods
Different methods have been developed and reported to assay L-asparaginase activity.
L-asparaginase activity can be evaluated by measuring the amount of ammonia or aspartic acid released during the reaction or by following the disappearance of asparagine [148, 149] . Both quantitative and qualitative techniques have been employed for estimation of L-asparaginase activity. Different methods are summarized in Table 6 [150].
Applications of L-Asparaginase
Anticancer Drug L-Asparaginase is used to treat ALL in combination with vincristine and a glucocorticoid (e.g., dexamethasone) [159] . Due to its antileukemic properties, L-asparaginase has been considered as a therapeutically important antitumor drug. L-asparaginase is a well-known chemotherapeutic agent which in combination with other drugs is used in the treatment of certain malignancies such as ALL (mainly in children), Hodgkin's disease, acute myelocytic leukemia, acute myelomonocytic leukemia, chronic lymphocytic leukemia, lymphosarcoma, reticulosarcoma, and melanosarcoma [6, 7] . L-asparagine is an essential amino acid for many tumor cells for protein synthesis and cell growth, while L-asparaginase possesses the ability to convert L-asparagine to aspartate; so, in the presence of Lasparaginase, malignant cells are deprived of important growth factor that results in depletion of asparagine and ultimately tumor cells die off [160] . L-asparaginase is widely reported in animals, plants, and microorganisms, but only the asparaginase from E. coli and E. chrysanthemi was approved to be used as part of a multiagent chemotherapy to treat ALL [161] . The significant disclosure by Kidd in 1953 that guinea pig serum could stifle the development of Gardner 6C3HED lymphosarcoma cells established subcutaneously in mice opened new doors for the advancement of Lasparaginase as a treatment for ALL [160] . Table 7 [160] summarizes the breakthroughs achieved during different time periods for the development of L-asparaginase as an anticancer drug.
Role of L-Asparaginase in Biosensor
L-asparaginase is also used for the development of a biosensor to analyze asparagine levels either in leukemia or the food industry [161] . Several spectroscopy techniques such as XRD, XPS, SEM, and TEM are currently used for L-asparagine analysis, but high cost and tedious procedures make them less favorable [162] . Over such a situation, biosensor technology can be a reliable, cheap, and user-friendly approach.
The mechanism of action of the biosensor is based on asparaginase activity, ammonium ions produced from the hydrolysis of asparagine cause a change in pH resulting in the change of color and absorption [163] .
L−asparagine L− aspartic acid þ ammonia Table 6 Summary of assays for L-asparaginase activity determination [150] No. Assay Therefore, a very less costly substrate required. But the method is time consuming and not continuous [157] 6. Conductimetry
Asparagine or aspartate hydroxamate Ammonia and/or aspartate Increased conductivity owing to high yield of ammonia or aspartic acid in reaction mixture
Measurement is simple and instantaneous [158] Role of L-Asparaginase in Amino Acid Metabolism L-Asparaginase plays a vital role in the biosynthesis of an aspartic family of amino acids, namely lysine, threonine, and methionine. Besides Kreb's cycle, aspartic acid that is a direct precursor of lysine, and threonine, is also formed by the action of L-asparaginase enzyme [164] .
Role of L-Asparaginase in Food industry
Besides, L-asparaginase is also used widely as a food processing aid. Recent developments in food technology exhibited that a colorless and odorless crystalline solid, acrylamide (2-propenamide), is produced as a result of Millard reaction, when starchy foods are fried or baked at 120°C [165, 166] . Acrylamide is a neurotoxin and has been categorized as a carcinogenic to human [167] . In the food industry, acrylamide is largely derived from heat-induced reactions (Fig. 3) [35] between the α-amino group of the free amino acid asparagine and carbonyl groups of reducing sugars such as glucose during baking and frying [168] . Due to its ability to convert L-asparagine to L-aspartate, L-asparaginase promises to be a possible way to reduce the number of precursors for Millard reaction by pre-treating the starchy foods (potato and bread dough) with L-asparaginase, hence reducing the risk of acrylamide formation [169] . However, complete removal of acrylamide is not possible due to other asparagineindependent formation [21] . Certain fungal asparaginase used in food industries nowadays includes L-asparaginase from Aspergillus oryzae and Aspergillus niger [170] . 
Conclusion
In this review article, we have presented both earlier and recent developments that continue to support the importance of L-asparaginase both in clinical and food industry. L-asparaginase, an amidohydrolase enzyme, is a significant enzyme that owes wide range of applications and is involved in deamination of asparagine and glutamine. From last 38 years, a lot of explorations have been carried out to establish the role of L-asparaginase in cancer therapy. Though distributed widely in bacteria, fungi, actinomycetes, plants, and animals, microbial Lasparaginase has drawn considerable attention due to cost-effective and easy production from microbes especially bacteria. However, certain limitations such as hypersensitive effects, resistance, immunogenic complications, and short life of enzyme are connected with its applications. Moreover, yields of L-asparaginase are low since gene expression rate of this enzyme is very low. Besides, L-asparaginase is utilized as food processing aid in the food industry for the elimination of carcinogenic compound acrylamide. Therefore, the desire of the time is to explore and optimize the production and purification parameters from new sources of the enzyme so that we can come up with more potential and specific L-asparaginase enzyme preparations. On the basis of better understanding of recombinant technologies like molecular cloning and genetic engineering, it may be possible to design enzyme with less immunogenic effects, novel functionalities, and better half-life. Besides, the use of latest recombinant 
